Fontanilla, Vaniezw P.

HRN: 21-84-69  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2022
CEFUROXIME 750MG (VIAL)
08/29/2022
09/05/2022
IV
1.5g
Q8H
Nontoxic Goiter For Total Thyroidectomy
Waiting Final Action 
09/01/2022
CEFUROXIME 500MG (TAB)
09/01/2022
09/08/2022
PO
500mg
BID
Post Thyroidectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: